Actelion shares gain on report of progress in Sanofi talks
Share price had fallen by 7% recently as possible takeover of the firm failed to emerge
Share price had fallen by 7% recently as possible takeover of the firm failed to emerge
Swiss drugmaker Roche also touted as possible buyer for Europe’s largest biotech firm
Acquisition would add to the $246bn of pharmaceutical deals announced this year
Company has predicted 2015 core earnings growth to be in the mid-to-high-teen percentage range
Shire said to be considering a $18bn takeover of Swiss group to boost rare diseases business
Crosswords & puzzles to keep you challenged and entertained
Full general election coverage including analysis and results for all 43 constituencies
How does a post-Brexit world shape the identity and relationship of these islands
Weddings, Births, Deaths and other family notices